Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 21 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Helicobacter pylori status of the partner is not important in reinfection of eradicated patients

The importance of the role played by the partners of patients in reinfection following Helicobacter pylori eradication has been tested in a study from Madrid, Spain.

News image

fiogf49gjkf04

An evaluation of whether the Helicobacter pylori status of the patient's partner is important in reinfection after eradication success has been published in the August issue of The European Journal of Gastroenterology and Hepatology.

The research group that conducted the study also attempted to assess the possibility of testing for transmission of H. pylori among partners by using molecular methods.

A total of 120 patients in whom H. pylori had been eradicated were studied prospectively.

Endoscopy with biopsies and a 13C-urea breath test were performed 1 month after completing therapy.

The breath test was repeated in all patients at 6 and 12 months.

At the 1-year follow-up visit (or before if reinfection occurred), a breath test was also performed on the patient's partner.

Gastric biopsies from patients and gastric content obtained by the string test from partners was used in order to conduct the molecular study.

UreC, a product of the UreC gene, was obtained by enzymatic digestion with MseI and HhaI enzymes of a polymerase chain reaction (PCR) product of 1179 base pairs.

H. pylori recurrence:
Partner infected - 7.6%
Partner not infected - 3.6%
Eur J Gastroenterol Hepatol

The researchers then examined the heterogeneity of ureC using electrophoresis to generate different band patterns.

Reinfections were diagnosed in 4 patients at 6 months, and a further 4 from 6 to 12 months, producing an incidence rate of 6.8% per patient-year.

Of these reinfected patients, 87% (7 out of the eight) had partners who were H. pylori-positive.

However, there was also a high prevalence (76%) of H. pylori infection in the partners of patients that did not become reinfected following eradication therapy.

Following multivariate analysis, age of the patient, δ13CO2 value after therapy, and therapy regimen, were the only variables that correlated with H. pylori recurrence.

In contrast, family variables (H. pylori status of partner, breath test value of partner, length of time couple had lived together, number of children living at home, and household density) did not correlate with recurrence of infection.

H. pylori recurrence occurred in 7 of 92 (7.6%) patients when the partner was infected and in 1 of 28 (3.6%) patients when the partner was H. pylori-negative.

Therefore, even if the spouse was infected, 92.4% of patients remained uninfected 1 year after H. pylori eradication.

The molecular study revealed that H. pylori strains involved were different in all cases.

Concluding, the authors of the report observe that recurrence of H. pylori infection seems to be relatively infrequent, even if the patient's spouse is H. pylori-positive.

They add that the molecular study demonstrates that the strains in reinfected patients and their partners are different, suggesting that the patient's partner does not act as a reservoir for H. pylori reinfection.

Eur J Gastroenterol Hepatol 2002; 14(8): 865-871
09 August 2002

Go to top of page Email this page Email this page to a colleague

 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us